Ligand Pharmaceuticals
LGND
#2784
Rank
NZ$10.74 B
Marketcap
NZ$538.78
Share price
0.07%
Change (1 day)
73.65%
Change (1 year)

Earnings for Ligand Pharmaceuticals (LGND)

Earnings in 2026 (TTM): NZ$0.42 Billion

According to Ligand Pharmaceuticals's latest financial reports the company's current earnings are NZ$0.29 Billion. In 2025 the company made an earning of NZ$0.29 Billion, an increase over its 2024 earnings that were of NZ$9.87 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Ligand Pharmaceuticals from 1994 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) NZ$0.42 B45.48%
2025 NZ$0.29 B2848.57%
2024 NZ$9.87 M-91.37%
2023 NZ$0.11 B-7.59%
2022 NZ$0.12 B4%
2021 NZ$0.11 B296.42%
2020 NZ$30.02 M-97.97%
2019 NZ$1.48 B275.62%
2018 NZ$0.39 B237.48%
2017 NZ$0.11 B49.05%
2016 NZ$78.34 M55.41%
2015 NZ$50.41 M36.87%
2014 NZ$36.83 M29.59%
2013 NZ$28.42 M1309.35%
2012 NZ$2.01 M-43.97%
2011 NZ$3.59 M-113.19%
2010 -NZ$27.29 Million59.86%
2009 -NZ$17.08 Million-61.33%
2008 -NZ$44.15 Million-58.75%
2007 -NZ$0.11 Billion20.52%
2006 -NZ$88.8 Million81.27%
2005 -NZ$48.99 Million
2003 -NZ$34.11 Million-20.6%
2002 -NZ$42.96 Million4.38%
2001 -NZ$41.15 Million-48.83%
2000 -NZ$80.41 Million-19.74%
1999 -NZ$0.11 Billion-19.06%
1998 -NZ$0.13 Billion126.71%
1997 -NZ$54.6 Million-5.83%
1996 -NZ$57.98 Million136.23%
1995 -NZ$24.55 Million-33.97%
1994 -NZ$37.17 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$46.60 B 10,634.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$12.28 B 2,728.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$59.74 B 13,660.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$18.29 B 4,113.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
-NZ$0.86 Billion-297.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$13.67 B 3,049.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$21.18 B 4,778.11%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$14.03 B 3,131.39%๐Ÿ‡ฌ๐Ÿ‡ง UK
Spectrum Pharmaceuticals
SPPI
-NZ$0.12 Billion-125.35%๐Ÿ‡บ๐Ÿ‡ธ USA